In breast cancer, NLRP3 inflammasome, and IL-1β production promote the infiltration of myeloid cells such as myeloid-derived suppressor cells (MDSCs) and tumor-associated macrophages (TAMs), providing an inflammatory microenvironment thus promoting breast cancer progression (36). Here, NLRP3 is linked to neoplasm.